Measurement of low-energy backscatter factors using GAFCHROMIC film and OSLDs

Investigation of backscatter factor in medical radiography using anthropomorphic phantom by optically stimulated luminescence dosimeter

At the diagnostic reference level (DRL) related to medical radiation, DRL quantity for general radiography is the entrance surface dose (ESD). Calculation of the ESD in medical radiography requires the backscatter factor (BSF), but derivation of the BSF requires assessment of an irradiated simulation of a human body. The present study used optically stimulated luminescence (OSL) dosimeters and an anthropomorphic phantom as the irradiated body, and the BSF was calculated for different half value layer (HVL)s and field sizes. The need for different BSFs for different regions was also investigated by derivationing of the BSFs for different regions. The pelvis of a RANDO phantom was irradiated under the conditions of the HVL of 2.0, 3.1, and 4.6 mmAl; tube current of 200 mA; irradiation time of 0.1 s; source surface distance of 100 cm; and field sizes of 10 × 10 cm², 20 cm², 30 cm², and 40 cm². Measurement in air was performed under the same conditions. Several threads were stretched through the air with tissue paper placed on them and the nanoDot dosimeters placed on the paper. Four dosimeters were placed, and measurement was performed 5 times under each set of conditions. The compared radiographed regions were the skull, chest, and pelvis. The BSF increased with increasing HVL size and with increasing field size. The larger the HVL, the larger the difference between field sizes of 10 × 10 cm²and 40 × 40 cm²and the larger the increase in BSF relative to the increase in field size. The BSF differed by region, from large to small in the order chest, pelvis, and skull. The results thus showed that the BSF differs by the radiographed region. Thus, it is desirable to determine the BSF in each radiographed region by investigation with an anthropomorphic phantom.

Review of backscatter measurement in kilovoltage radiotherapy using novel detectors and reduction from lack of underlying scattering material

Lack of underlying material can lead to dose reduction in kilovoltage radiotherapy treatments because of backscatter reduction. Conversely, the use of lead shielding can lead to large dose enhancement close to the lead interface. GAFCHROMIC film has been shown to be of use in verification of local backscatter factors compared to reference data in codes of practice, but careful handling and multiple readings are required to reduce systematic uncertainties to between 3% and 4%. Monte Carlo modeling of the specific treatment unit should be performed in cases which are found to differ from reference values before alternative values are adopted clinically, but these cases are expected to be few. GAFCHROMIC film may also be used to estimate backscatter reduction more readily than customized ionization chambers, for a range of beam qualities, applicator sizes and depth, with and without lead shielding. Differences were found between different studies, and it is not clear to what extent these are due to variation in equipment and/or technique. However, a layer of wax around lead shielding of 1 mm thickness should be sufficient to eliminate lead enhancement effects for all kilovoltage energies from 40 kV to 300 kV.